Benefits of
participating
The data from the PCR has many
significant impacts in research, development, and education.
- Provides a cross-sectional view of
multiple clinical and demographic aspects of prostate cancer that may be
studied in detail using targeted, prospective study design or using health
statistics.
- Identifies whether clinicians are
managing the disease in accordance with the principles of evidence-based
practice.
- Collects up-to-date information about
patterns of care and enables oversight of changing patterns of disease
demographic and management.
- Enables clinicians to compare their own
patient population and therapeutic management with that of other
clinicians (NB. No clinician identifying information will be released by
the PCR).
- May be used to assist in the design of
clinical trials, including identifying questions for study.
- Provide clinicians and institutions with
mortality and morbidity data associated with various risk and treatment
groups, both for their own patients and the wider cohort of men with
prostate cancer.
- May be used as an educational tool for
clinicians and students.
Enrolment
Only clinicians working within contributing
hospitals are eligible to enrol in the PCR. While enrolment is
voluntary, it is important that the registry collects information from close
to, if not all, the eligible population. The registry would serve limited
purpose if it did not collect representative data from both patients and
clinicians.
Clinicians are informed about the
registry via an information sheet. To date, NO clinicians have refused to
participate in the PCR. This is the strength of the registry and testament to
the willingness of Victorian clinicians to monitor their performance and
constantly strive to provide excellent patient care.
Accessing the PCR
Clinicians participating in the
PCR will be provided with a login and password to enable them to access their
own patient-level data via a secure gateway. Contact the registry custodian (Contact Us) for further
details.